Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02).
A. Diab, N. Tannir, S. Bentebibel, P. Hwu +19 more
Researcher profile · Semantic Scholar
A. Diab, N. Tannir, S. Bentebibel, P. Hwu +19 more
G. Pavlopoulos, A. Oulas, Ernesto Iacucci, A. Sifrim +4 more
Charalampos N. Moschopoulos, G. Pavlopoulos, Ernesto Iacucci, J. Aerts +3 more
Michael E. Hurwitz, D. Cho, A. Balar, B. Curti +13 more
G. Pavlopoulos, Ernesto Iacucci, I. Iliopoulos, P. Bagos
Ernesto Iacucci, L. Tranchevent, D. Popović, G. Pavlopoulos +3 more
Ernesto Iacucci, F. Ojeda, B. De Moor, Y. Moreau
P. Savage, S. Saleh, Y.-C. Wang, T. Revil +13 more
G. Pavlopoulos, A. Oulas, Ernesto Iacucci, A. Sifrim +4 more
Ernesto Iacucci, L. Tranchevent, D. Popović, G. Pavlopoulos +3 more
I. Ragoussis, P. Savage, Yu-Chang Wang, T. Revil +8 more
Ernesto Iacucci, S. X. de Souza, Y. Moreau
Ernesto Iacucci, D. Popović, G. Pavlopoulos, L. Tranchevent +3 more
Ernesto Iacucci, H. Zingg, T. Perkins